60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Wixela]

RxCUI
2110510
RxNorm name
60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Wixela]
Display name
60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Wixela]
Full name
60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Wixela]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Wixela InhubFLUTICASONE PROPIONATE AND SALMETEROLMylan Pharmaceuticals Inc.3beef422-8a07-4a45-9ba6-414511e4b7e22022-08-29Warnings, Adverse reactionsExact identifier
rxcui: 2110510

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3beef422-8a07-4a45-9ba6-414511e4b7e2Wixela Inhub 100/50 MCG/INHAL Dry Powder Inhaler, 60 Actuations [PSN] · 60 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler [Wixela] [SBD] · Wixela Inhub 100/50 MCG/INHAL Dry Powder Inhaler, 60 Actuations [SY]36These highlights do not include all the information needed to use WIXELA INHUB ® safely and effectively. See full prescribing information for WIXELA INHUB ® . WIXELA INHUB ® (fluticasone propionate and salmeterol inhalation powder), for oral inhalation use Initial U.S. Approval: 200020220829